AzTrials
AzTrials

Diagnostic ImagingCREAITEDNCT07675694

AI Timing in Chest X-ray Interpretation Using Eye-Tracking

A study testing Original CXR First Timing and AI Output First Timing in people with Diagnostic Imaging and Eye Tracking, run by University Hospitals, Leicester at 1 site in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Chest X-rays are commonly used to help diagnose and manage chest conditions. Artificial intelligence (AI) tools are increasingly being used to support chest X-ray interpretation. However, it is not yet clear whether the timing of AI information affects how clinicians review images, make decisions, and use AI support. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Original CXR First Timing and AI Output First Timing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited Kingdom
Study dates
30 Jun 2026to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Main reader study:
  • Healthcare professionals aged 18 years or over
  • Registered to practise in the UK
  • Employed by the NHS or another healthcare service operating in the UK
  • Current or recent, within the last 3 years, clinical experience involving chest X-ray interpretation, review, or use in clinical practice
  • Able to attend two onsite study sessions at University Hospitals of Leicester NHS Trust at mutually agreed times
Show all 14Show fewer
  • Able and willing to provide written informed consent
  • Compatible with the eye-tracking equipment
  • Supplementary survey:
  • Adults aged 18 years or over
  • Live in the UK or have used the NHS or another UK healthcare service within the last 5 years
  • Able to provide informed electronic consent
  • Belong to one of the following respondent groups: healthcare professionals or healthcare staff, patients or carers, or members of the public
  • Healthcare professional respondents may include adults involved in requesting, interpreting, checking, or acting on chest X-ray findings in clinical practice

Who cannot join

  • Main reader study:
  • Inability to attend both onsite study sessions at University Hospitals of Leicester NHS Trust
  • Eye-tracking incompatibility, such as visual, neurological, or physical conditions preventing adequate gaze tracking or participant comfort
  • Direct involvement in selection, adjudication, or preparation of the chest X-rays used in the study
  • Conflicts of interest, including direct involvement in development of the AI system under evaluation
  • Prior participation in a closely related AI chest X-ray study where overlap in image sets or study procedures may compromise validity, assessed on a case-by-case basis
Show all 11Show fewer
  • Supplementary survey:
  • Aged under 18 years
  • Does not live in the UK and has not used the NHS or another UK healthcare service within the last 5 years
  • Unable to provide informed electronic consent
  • Does not meet one of the eligible respondent groups for the survey

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United Kingdom1 site, 1 recruiting
  • University Hospitals of Leicester NHS Trust

    Leicester, Leicestershire, LE1 5WW

    Richard Farley, +44116 2586237, richard.farley1@nhs.net

    Recruiting

Other trials in United Kingdom

About this study

Official title: A Within-Subject Eye-Tracking Study Examining How the Timing of AI Decision Support Influences Visual Search Behaviour, Diagnostic Accuracy, and Trust During Chest X-ray Interpretation

Chest X-rays are commonly used to help diagnose and manage chest conditions. Artificial intelligence (AI) tools are increasingly being used to support chest X-ray interpretation. However, it is not yet clear whether the timing of AI information affects how clinicians review images, make decisions, and use AI support.

This study will look at whether showing AI information before or after a clinician first reviews a chest X-ray changes how they look at the image, how long they take, their interpretation decisions, their confidence, and their trust in AI support.

Read more

Healthcare professional participants will complete two chest X-ray interpretation sessions in a controlled NHS research setting. During each session, participants will review de-identified chest X-ray images while wearing eye-tracking equipment. Eye-tracking will record where a participant looks on the image and how long they spend looking at different areas.

In one session, AI information will be shown before the participant reviews the chest X-ray. In the other session, AI information will be shown after the participant has first reviewed the chest X-ray. The order of these two sessions will be balanced across participants.

The study uses de-identified chest X-ray images from existing examinations. It does not involve patients directly, does not change clinical care, and no clinical decisions will be made from the study readings. Participants will also complete a short questionnaire about their experience of using AI support. A separate anonymous survey will collect wider views from clinicians, patients, members of the public, and healthcare staff about the use of AI in chest X-ray interpretation.

Read the detailed description

CREAITED is a behavioural diagnostic reader study examining how the timing of artificial intelligence (AI) decision-support information influences chest X-ray interpretation by healthcare professionals. The study focuses on whether showing AI information before or after a participant first reviews a chest X-ray affects visual search behaviour, interpretation time, clinical decision-making, confidence, and trust in AI support.

Chest X-rays are widely used in clinical practice, but interpretation can be challenging because findings may be subtle and normal anatomy can overlap with abnormalities. AI systems are increasingly used to support image interpretation by highlighting suspected abnormalities. However, less is known about how clinicians use AI information during reporting tasks, including whether seeing AI output early changes attention, reliance, confidence, or interpretation strategy. Current clinical guidance generally supports independent image review before consulting decision-support tools, but direct evidence on AI timing in chest X-ray interpretation remains limited. This study is designed to provide controlled evidence on that question.

The main reader study is a single-site study at University Hospitals of Leicester NHS Trust. It uses a within-subject, counterbalanced, multi-reader, multi-case design. The exposure of interest is the timing of AI decision-support presentation during chest X-ray interpretation. The AI information is used only within the research task and is not used to guide real patient care.

Healthcare professional participants will complete two chest X-ray interpretation sessions in a controlled NHS research setting. Participants will include clinicians and healthcare professionals who interpret, review, check, or act on chest X-ray findings as part of their current or recent professional role. The study is not designed to assess individual competence. Individual participant results will not be used for employment, appraisal, training progression, formal assessment, or performance management.

Each participant will complete both AI timing conditions. In one session, AI information will be shown before the participant reviews the chest X-ray. In the other session, the participant will first review the chest X-ray without AI information, and AI information will then be shown afterwards. The order of these two-timing conditions will be balanced across participants using a pre-generated allocation schedule. The two sessions will be separated by at least four weeks to reduce recall and learning effects.

Each case will use a two-phase interpretation process. In the first phase, only one information source is shown, either the original chest X-ray or the AI output, depending on the timing condition. In the second phase, the alternative information source is introduced so that both the chest X-ray and AI information can be viewed. Participants complete a structured interpretation response after the first phase and may review or revise their response after seeing both information sources before submitting their final response for that case.

During each session, participants will review de-identified chest X-ray images using a dedicated diagnostic reporting workstation in a controlled reporting environment. The reader study is designed for approximately 20 complete participant datasets. Each participant will review 25 study chest X-ray cases per session across two sessions. The same study image set will be used across both sessions, with case order independently randomised for each session. Warm-up cases from a separate image pool will be used at the start of each session to familiarise participants with the task and equipment, and these warm-up cases will not be included in the main analysis.

The image set will include a mix of normal and abnormal chest X-rays and a range of diagnostic difficulty. Cases will be selected from routine clinical imaging and de-identified before use in the study. Ground truth labels and image areas of interest will be defined through a structured clinical review process. These reference data will support analysis of participant interpretation, localisation, and visual search behaviour.

Participants will wear lightweight eye-tracking equipment during the interpretation task. Eye-tracking will record where participants look on the image and how long they spend looking at different areas. These data will be used to assess visual search behaviour, including how attention is distributed across image areas, how participants view areas highlighted by the AI, and whether visual search differs between the AI-first and chest X-ray-first timing conditions.

Study sessions will be self-paced, with optional breaks to reduce fatigue. A researcher will be present to monitor equipment and provide technical support if needed, while minimising interaction that could influence participant behaviour. After completing the reader study sessions, participants will complete a short questionnaire about confidence, trust, perceived usefulness, workflow impact, and the influence of AI timing. Participants will also be debriefed about the study design and the reason for comparing different AI timing conditions.

The study will collect de-identified imaging data, eye-tracking data, structured reporting responses, timing data, localisation information, and questionnaire responses. The primary outcome is case interpretation time, measured for each chest X-ray case. Other outcomes include diagnostic performance, clinical interpretation or management responses, confidence in decision-making, participant perceptions of AI support, and eye-tracking measures of visual search behaviour.

The reader study uses de-identified chest X-ray images from existing examinations. No patients are recruited directly into the reader study, no clinical care is changed, and no clinical decisions will be made from participant study readings. The study does not involve investigational medicinal products, and no biological samples are collected.

Patient and public involvement informed the development of the study. Input from patients, members of the public, healthcare staff, and other stakeholders helped refine the focus on trust, confidence, transparency, human oversight, communication preferences, and the timing of AI information. This input also informed participant-facing materials and the topic areas included in the supplementary survey.

Alongside the main reader study, a separate anonymous supplementary survey will collect wider views about AI use in chest X-ray interpretation. This survey will be administered remotely and will be open to relevant groups, including clinicians, patients, members of the public, and healthcare staff. It will explore views on trust, safety, responsibility, communication, acceptability, governance, and expectations of AI-supported chest X-ray interpretation. The supplementary survey is independent of the reader study sessions and does not influence the image interpretation task.

Study data will be handled using study identifiers and secure NHS systems. Results will be reported in aggregate form so that individual participants are not identified. The findings are intended to help inform safer and more effective use of AI decision support in chest X-ray interpretation.

Being tested
Original CXR First Timing, AI Output First Timing
Keywords
Artificial intelligence timing, Chest X-ray interpretation, Visual search behaviour, Diagnostic accuracy, Trust in automation, Automation bias, Clinician confidence, Decision support systems, Human-AI interaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Original CXR First TimingBehavioural

    Participants first review the original chest X-ray without AI output and complete an initial structured interpretation response. AI output is then introduced, and participants may review or revise their response before submitting the final response for that case.

  • AI Output First TimingBehavioural

    Participants first view AI output before reviewing the original chest X-ray. The original chest X-ray is then introduced, and participants complete or revise their structured interpretation response before submitting the final response for that case.

Study groups in NCT07675694
Study groupRoleWhat they receive
Original CXR First SequenceExperimentalParticipants complete the original chest X-ray first timing condition in Session 1, followed by the AI output first timing condition in Session 2. Sessions are separated by at least four weeks.
Receives: Behavioral: Original CXR First Timing; Behavioral: AI Output First Timing
AI Output First SequenceExperimentalParticipants complete the AI output first timing condition in Session 1, followed by the original chest X-ray first timing condition in Session 2. Sessions are separated by at least four weeks.
Receives: Behavioral: Original CXR First Timing; Behavioral: AI Output First Timing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Chest X-ray Case Interpretation Time

    Case interpretation time is the duration, in seconds, from initial case display to final structured report submission. Change in case interpretation time will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.

    Measured: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks

  2. Change in Chest X-ray Case Diagnostic Accuracy

    Diagnostic accuracy will be assessed using structured report outcomes compared with clinician-verified chest X-ray ground truth. Each participant's final structured interpretation for each chest X-ray case will be compared with the verified study ground truth for that case. Change in diagnostic accuracy will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.

    Measured: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks

  3. Change in Chest X-ray Case Visual Search Behaviour

    Visual search behaviour will be assessed using predefined eye-tracking metrics that capture gaze location and search behaviour during chest X-ray interpretation. Metrics include time to first fixation, hit time, dwell time within abnormal case areas of interest, fixation count, mean fixation duration, revisit count, and fixation dispersion. Change in visual search behaviour will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.

    Measured: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks

  4. Trust in AI Support After Reader-Study Completion

    Trust in AI support will be assessed using structured questionnaire ratings after participants have completed both Session 1 and Session 2. This measure captures participants' overall perceived usefulness, reliance on AI support, and willingness to revise decisions after reviewing AI information.

    Measured: Immediately after Session 2, anticipated average 5 weeks after enrolment

Secondary outcomes (5)
  1. Change in Chest X-ray Case Clinical Management Recommendations

    Clinical management recommendations will be recorded from participants' structured report responses for each chest X-ray case. Change in clinical management recommendations will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.

    Measured: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks

  2. Change in Chet X-ray Case Decision Confidence

    Decision confidence will be recorded as the participant's confidence rating in their final diagnostic judgement for each chest X-ray case. Change in decision confidence will be measured between Session 1 and Session 2, displaying either original chest X-ray first or AI output first.

    Measured: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks

  3. Overall Reflective Confidence After Reader-Study Completion

    Overall reflective confidence will be assessed using structured questionnaire ratings after participants completed both Session 1 and Session 2. This measure captures participants' overall perceived confidence in their interpretive decisions across the reader study.

    Measured: Immediately after Session 2, anticipated average 5 weeks after enrolment

  4. Participant Perceptions of AI Support After Reader-Study Completion

    Participant perceptions of AI support will be assessed using a post-study questionnaire after participants completed both Session 1 and Session 2. This measure captures participants' overall perceptions of usability, clarity, workflow implications, communication preferences, and responsibility.

    Measured: Immediately after Session 2, anticipated average 5 weeks after enrolment

  5. Broader Attitudes Toward AI in Chest X-ray Interpretation

    Broader attitudes toward AI in chest X-ray interpretation will be assessed using a separate anonymous online supplementary survey. The survey will collect views on trust, responsibility, communication preferences, acceptability, and related perceptions from patients, members of the public, healthcare professionals, and healthcare staff.

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jun 2026
  2. Study start30 Jun 2026
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Model description
Participants are randomly assigned to one of two session orders. In one order, participants review the chest X-ray first in Session 1 and the AI information first in Session 2. In the other order, participants review the AI information first in Session 1 and the chest X-ray first in Session 2. Sessions are separated by at least four weeks.
Masking
None (open label)
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07675694
Sponsor's protocol ID
204269
Other IDs
347920, 26/EE/0111
Acronym
CREAITED
Status last verified
Jul 2026
First submitted
10 Jun 2026
Last updated
6 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Original CXR First Timing and AI Output First Timing in people with Diagnostic Imaging and Eye Tracking, run by University Hospitals, Leicester at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 6 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Richard Farley (+44116258 6237, richard.farley1@nhs.net), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Chest X-ray Case Interpretation Time (time frame: Session 1 at enrolment and Session 2 at least 4 weeks later, anticipated average 5 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in